| 12th Oct 2026 7:00 am |
RNS |
Notice of Interim Results Investor Meeting |
| 6th Oct 2026 7:30 am |
RNS |
Capital Access Window - Avacta Group Plc |
| 6th Oct 2026 7:00 am |
RNS |
Results of Placing and Subscription |
| 5th Oct 2026 4:22 pm |
RNS |
Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am |
RNS |
Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am |
RNS |
Capital Access Window |
| 30th Sep 2026 7:00 am |
RNS |
Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am |
RNS-R |
pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am |
RNS |
Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am |
RNS |
Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am |
RNS |
Mats Blom to Board as Chair of Audit Committee |
| 4th Sep 2026 7:00 am |
RNS |
Accelerated Payment Convertible Bond Installment |
| 1st Sep 2026 7:00 am |
RNS |
Share Option Awards to Management Team at Avacta |
| 9th Jul 2026 7:00 am |
RNS |
Accelerated Amortized Payment of Bond Installment |
| 8th Jul 2026 7:00 am |
RNS |
Avacta Appoints Patrick Vink Deputy Chairman |
| 25th Jun 2026 7:00 am |
RNS |
Platform-Validating Data with Faridoxorubicin |
| 25th Jun 2026 7:00 am |
RNS |
FDA Agreement on Pivotal Trial Design for AVA6000 |
| 23rd Jun 2026 7:00 am |
RNS |
Result of AGM |
| 22nd Jun 2026 7:00 am |
RNS |
Year-to-date business update ahead of AGM |
| 5th Jun 2026 7:00 am |
RNS |
Oversubscribed Strategic Equity Fundraise of £9m |
| 1st Jun 2026 3:00 pm |
RNS |
Block Listing - Application to AIM |
| 1st Jun 2026 7:00 am |
RNS |
Clinical data on AVA6000 in salivary gland cancers |
| 29th May 2026 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 29th May 2026 7:00 am |
RNS |
Board Director Changes |
| 19th May 2026 7:00 am |
RNS |
Unaudited Preliminary Full Year 2025 Results |
| 13th May 2026 7:00 am |
RNS |
Notice of Preliminary Results and Presentation |
| 13th May 2026 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |
| 6th May 2026 7:00 am |
RNS |
Pre|CISION® payload release vs approved ADCs |
| 28th Apr 2026 7:00 am |
RNS |
Block Listing Six Monthly Return |
| 21st Apr 2026 7:00 am |
RNS |
Avacta data AACR underline AVA6103 profile |
| 14th Apr 2026 11:37 am |
RNS-R |
Christina Coughlin - In Vivo 2026 Rising Leader |
| 9th Apr 2026 7:00 am |
RNS |
Q1 2026 Business Update |
| 8th Apr 2026 7:00 am |
RNS-R |
Avacta Announces Science Day 2026 |
| 31st Mar 2026 7:00 am |
RNS |
First patient treated in Phase 1 trial of AVA6103 |
| 27th Mar 2026 7:00 am |
RNS |
Result of Oversubscribed Fundraise |
| 26th Mar 2026 5:16 pm |
RNS |
Proposed Fundraise to raise approximately £10m |
| 26th Mar 2026 4:44 pm |
RNS |
Issue of Equity |
| 17th Mar 2026 7:00 am |
RNS-R |
Presentations of pre|CISION® Platform Candidates |
| 17th Mar 2026 7:00 am |
RNS-R |
Presentations of pre|CISION® Platform Candidates |
| 16th Mar 2026 7:00 am |
RNS |
Phase 1 study opening for AVA6103 |
